Jinn Wu

Jinn Wu

Directeur/Membre du Conseil chez ATHENEXPAR
77 ans
Health Technology
Commercial Services
Process Industries

Profil

Jinn Wu is the founder of XenoBiotic Laboratories, Inc. He is currently the Chairman at AiViva BioPharma, Inc. and AiViva Holding Ltd. He is also an Independent Director at Athenex, Inc. In addition, he is a Member of the American Chemical Society, the American Association of Pharmaceutical Scientists, the International Society for the Study of Xenobiotics, and the American Society of Pharmacognosy.
Dr. Wu's former positions include being a Director at Enhance Biotech, Inc., Ardent Pharmaceuticals, Inc., and Handa Pharmaceuticals, Inc. He was also a Research Scientist at FMC Corp.
Furthermore, he was a Member-College of Pharmacy at The Ohio State University from 2007 to 2013 and served as the Chief Scientific Officer & Senior Vice President at Wuxi Apptec, Inc. from 2015 to 2016.
Dr. Wu obtained his doctorate degree from The Ohio State University.

Postes actifs de Jinn Wu

SociétésPosteDébut
ATHENEXPAR Directeur/Membre du Conseil 01/04/2007
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Directeur Général 01/09/2017
Président 01/01/2016
Président -

Anciens postes connus de Jinn Wu

SociétésPosteFin
Directeur Technique/Scientifique/R&D 01/01/2016
░░░ ░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
Voir l'expérience en détail de Jinn Wu

Formation de Jinn Wu

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

88

Relations au 1er degré

14

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées14

Process Industries

Health Technology

Health Technology

Commercial Services

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Technology

Technology Services

Health Technology

Health Technology

Finance

- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇